BIOS Capital Management, LP - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 13, 2026, for the 2025 Q4 period, BIOS Capital Management, LP held in its portfolio 6 assets valued at $82,622,742 (i.e. $82.62M).

The most valuable assets in the portfolio included: ACTUATE THERAPEUTICS INC ($61.51M), COGNITION THERAPEUTICS INC ($8.10M), and OPUS GENETICS INC ($7.40M).

The chart below shows the top 6 valuable assets, and the table below shows the top 6 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in BIOS Capital Management, LP Portfolio

ACTUATE THERAPEUTICS INC

COGNITION THERAPEUTICS INC

OPUS GENETICS INC

LANTERN PHARMA INC

REIN THERAPEUTICS INC

IN8BIO INC

BIOS Capital Management, LP - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
ACTUATE THERAPEUTICS INC	10049996	61505976	COM
COGNITION THERAPEUTICS INC	6000000	8100001	COM
OPUS GENETICS INC	3683429	7403692	COM
LANTERN PHARMA INC	1009507	3058806	COM
REIN THERAPEUTICS INC	1690751	1961271	COM NEW
IN8BIO INC	253417	592996	COM NEW